1,180
Views
0
CrossRef citations to date
0
Altmetric
Hemodialysis and Peritoneal Dialysis

Association of albumin to non-high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients

, , , , , , , , , ORCID Icon, ORCID Icon, , , & show all
Article: 2299601 | Received 17 Jul 2023, Accepted 21 Dec 2023, Published online: 09 Jan 2024
 

Abstract

Objective

Malnutrition and inflammation are associated with mortality in peritoneal dialysis (PD) patients. Serum albumin and non-high-density lipoprotein cholesterol (non-HDL-C) are independently associated with mortality in PD patients. Combining albumin and non-HDL-C with mortality may be more plausible in clinical practice.

Methods

This retrospective cohort study included 1954 Chinese PD patients from 1 January 2009 to 31 December 2016. Kaplan–Meier curve was used to determine the relationship between albumin to non-HDL-C ratio and all-cause mortality. Cox regression analysis was applied to assess the independent predictive value while adjusting for confounding factors. Competitive risk analysis was used to examine the effects of other outcomes on all-cause mortality prognosis.

Results

In the 33-month follow-up period, there were 538 all-cause deaths. Kaplan–Meier analysis presented significant differences in all-cause mortality. Multivariate Cox regression showed that the risk of all-cause mortality was lower in the moderate group (9.36–12.79) (HR, 0.731; 95% CI, 0.593–0.902, p = 0.004) and the highest group (>12.79) (HR, 0.705; 95% CI, 0.565–0.879, p = 0.002) compared to the lowest group (≤9.36). Competitive risk analysis revealed significant differences for all-cause mortality (p < 0.001), while there was no statistical significance for other competing events.

Conclusions

Low albumin to non-HDL-C ratio was associated with a high risk of all-cause mortality in PD patients. It may serve as a potential prognostic biomarker in PD patients.

Acknowledgments

The authors are grateful to all the participants in this study.

Authors Contribution

YJX: Project development, Manuscript writing; XRF: Data analysis and data collection; YQG: Data analysis; XJZ: Data collection; FFP: Data collection; QZ: Provide statistical support; XFW: Data collection; XYW: Assist in data analysis; NT: Data collection; QDX: Data collection; JBL: Data management; JL: Project development, Manuscript editing, Funding. YQW: Data management, Manuscript editing, Funding. All authors have read and approved the manuscript.

Data availability statement

All data generated or analyzed during this study are included in this published article.

Geolocation information

The research conducted in this study focuses on a specific geographic area located in Guangzhou, Guangdong Province, China.

DeclarationsEthics and consent to participate

All procedures performed in this study involving human participants were following the ethical standards of the institution (IRB approval number 2019-hg-ks-04) and with the 1964 Helsinki Declaration as well as its later amendments or comparable ethical standards. This study was warranted by the Institutional Review Board of two PD.

Consent to participate and publication

Owing to we had collected the existing medical records, written informed consent was not required.

Consent for publication

The data released by our research would not compromise anonymity or confidentiality, nor violate local data protection laws. The researchers disclosed no names or other identifying information related to respondents and their parents or guardian in this manuscript.

Competing Interests

The authors declared that they had no financial conflicts of interest.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by [the Science and Technology Program of Guangzhou, China #1] under Grant [202002030336]; [the Scientific and Technological Project of Combining Traditional Chinese Medicine with Traditional Chinese and Western Medicine of Guangzhou, China #2] under Grant [20182A011017]; [Guangzhou Key Discipline of Urology; Second Affiliated Hospital of Guangzhou Medical University Fund Project #3] under Grant [2021-LCYJ-04]; [Clinical Research Project of the Second Affiliated Hospital of Guangzhou Medical University #4] under Grant [2021-LCYJ-DZX-03, 2022-LCYJ-YYDZX-03]; [The open research funds from the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital #4] under Grant [202201-304] and [The Natural Science Foundation of Guangdong Province, China #5] under Grant [2023A1515011721].